NMA: Nonprescription Medicines Academy

Patient Safety Alerts

January 28th, 2013

Recall of Zicam Extreme Congestion Relief
Matrixx Initiatives has voluntarily recalled one lot of Zicam Extreme Congestion Relief nasal gel spray. The company is taking this step after finding a small amount of Burkholderia cepacia in a single sample of the product taken from the affected lot (lot 2J23, expiration 09/15). The problem was detected during a routine review at the manufacturing facility. Tests on additional samples from the same lot have shown no evidence of the organism.

MAXILOSS Weight Advanced
The FDA is advising consumers not to purchase or use MAXILOSS Weight Advanced, a product promoted and sold for weight loss on various websites (including www.dreamlifeweightloss.com) and in some retail stores. FDA laboratory analysis confirmed that the product contains sibutramine, a controlled substance that was removed from the market in October 2010 for safety reasons. Sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke.